Tuesday, October 27, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Friday Shorts and Followups: Premiums, GLP-1 Ingredient Safety, Arbitration Profits, and Vaccine Views

Source: Claxton, G et al 2026 Employer Health Benefits Survey, KFF, October 22,

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 23 05:07 ETSource: Substack

From the source

Friday Shorts and Followups: Premiums, GLP-1 Ingredient Safety, Arbitration Profits, and Vaccine Views

Source: Claxton, G et al 2026 Employer Health Benefits Survey, KFF, October 22, 2026

Read at employercoverage.substack.com
PeptiPrescribed peptides from $99/moSee all →